** Shares of ReNerve RNV.AX fall as much as 29% to A$0.11, their lowest level since October 27
** Stock set for its weakest session ever, if current trends hold
** Medical device maker says firm commitments received to raise A$3.2 million ($2.07 million) at an issue price of A$0.12 per share
** Issue price at a 22.6% discount to the stock's last close
** Funds will be used for acceleration of the sales and marketing programmes for the co's product lines already on market, others
** About 3.9 mln shares traded, 6x the 30-day average
** YTD, stock down 34.3%, including current session's move
($1 = 1.5444 Australian dollars)
(Reporting by Ananya Verma in Bengaluru)
((ananya.verma@thomsonreuters.com;))

